19. Talib F.doc J Bagh College Dentistry Vol. 27(4), December 2015 Antibacterial effect Oral and Maxillofacial Surgery and Periodontics 119 An Evaluation of Serum and Salivary Adipokines (Leptin and Resistin) Levels in Periodontal Health and Disease Talib Ali Karam, B.D.S. (1) Khulood A. Al-Safi, B.D.S., M.Sc., Ph.D. (2) ABSTRACT Background: With the start of the current century, increased the interest in the role of the adipose tissue derived substances that named adipokines in the inflammatory diseases of the human being including the inflammatory periodontal disease, but scientific evidences were not clearly demonstrate the association between these adipokines and periodontal pathologies. Materials and Methods: Forty two subjects male only with normal body mass index were selected for the study with an age ranged (30-39 years). Samples were divided into three groups of 14 subjects in each group based on clinical periodontal parameters; clinically healthy gingiva (group I), gingivitis group (group II) and chronic periodontitis patients group (group III), from whom saliva and serum samples were collected for estimating the levels of leptin and resistin using Enzyme-Linked Immuno Sorbent Assay (ELISA). Results: The results showed that the serum level of leptin and resistin were significantly higher in chronic periodontitis patient (9.81 ng/ml, 6.55 ng/ml) respectively as compared to gingivitis and healthy control groups (leptin; 8.10 ng/ml, ng/ml, resistin; 5.85 ng/ml, 5.45 ng/ml) respectively. On the other hand the level of leptin in saliva of patients with chronic periodontitis (0.17 ng/ml) was significantly lower than that of its salivary levels in gingivitis and healthy control groups (0.21 ng/ml, 0.29 ng/ml) respectively. Whereas, salivary resistin levels was significantly higher in chronic periodontitis patient(14.45 ng/ml) when compared to the gingivitis group (11.59 ng/ml) and the health control group (6.43 ng/ml). Conclusions: Concomitant raise in serum leptin, serum resistin and salivary resistin, while a sensible reduction in salivary leptin with conversion from periodontal health state to periodontal disease state. These finding may draw a suggestion on the role of leptin and resistin in the relation between periodontal disease and the systemic health since the increase in their level were associated with a various systemic pathologies. Keywords: Adipocytokine, Leptin, Resistin, Periodontal disease. (J Bagh Coll Dentistry 2015; 27(4):119-124). INTRODUCTION Periodontal disease is a chronic microbial and inflammatory process characterized by the presence of sulcular pathogenic bacteria, impaired host immune response and destruction of the connective tissue attachment (1). Biochemical signaling involving three biological phases (inflammation, connective tissue degradation and alveolar bone turnover) contributes to the clinical morbidity observed in the affected tissues, in these biological phases, circulating molecules have been detected at elevated levels in the whole saliva and gingival crevicular fluid (GCF) of patients with periodontal disease making them putative biomarkers of the disease (2-4). It has been proposed that appropriate cytokine production results in protective immunity, while inappropriate cytokine production leads to tissue destruction and disease progression (5). Adipose tissue participates in the regulation of energy homeostasis and is an active endocrine organ that secretes more than 50 biologically active substances, collectively termed adipokines. Adipokines such as the hormone-like proteins: leptin, resistin and adiponectin (6). (1) Master Student. Department of Periodontics, College of Dentistry, University of Baghdad. (2) Professor, Department of Periodontics, College of Dentistry, University of Baghdad. Leptin is a non-glycosylated peptide hormone that has been classified as a cytokine as it shows structural similarities to the long chain helical cytokine family interleukin (IL)-6 (7). Ahima and Flier suggested that leptin orchestrates the host response to infectious and inflammatory stimuli as it stimulates the immune system by enhancing pro-inflammatory cytokine production and phagocytosis by macrophages (8). It was shown that leptin synthesis is increased by a number of inflammatory stimuli, including interleukin (IL)-1, IL-6, tumor necrosis factor alfa (TNF-α), and lipopolysaccharid (LPS) (9). As the gingival disease progressed, there is significant decrease in the gingival leptin concentration, GCF leptin concentration and significant increase in the plasma leptin concentration (10,11). Resistin is a polypeptide hormone that is expressed abundantly in adipose tissues of mice; however, in humans, resistin is expressed at very low levels in adipocytes (12). Human resistin acts as a pro-inflammatory molecule and stimulates the synthesis and secretion of TNF-α and interleukin (IL-12) (13). In addition to TNF- α and IL-6, resistin may participate in inflammatory processes caused by bacterial infections(14). Periodontitis was significantly associated with increased levels of resistin, after adjustment for gender, smoking, fasting glucose, and body mass index (BMI) (15,16). J Bagh College Dentistry Vol. 27(4), December 2015 Antibacterial effect Oral and Maxillofacial Surgery and Periodontics 120 Potential role for resistin in bone metabolism was suggested by increased resistin levels that coincided with osteoclast differentiation (17). This study aimed to evaluate the salivary and serum levels of leptin and resistin in periodontal health and disease (individuals with clinically healthy gingiva, gingivitis and chronic periodontitis). MATERIALS AND METHODS A total of 42 males with normal body mass index according to WHO criteria were participated in the study. They were divided into three groups, based on clinical examination according to Gingival index (GI), Probing pocket depth (PPD), Clinical attachment level (CAL). Group I (control group): Fourteen individual with clinically healthy gingiva, and this was defined by GI scores (<0.7) and with no periodontal pocketing or attachment loss. For standardization of biochemical parameters. Group II Gingivitis Patient: Fourteen individual with gingivitis, and this was defined by GI scores (>0.7) and with no periodontal pocketing or attachment loss. Group III Chronic Periodontitis: Fourteen patients with chronic periodontitis, and this was defined by the presence of at least four sites with PPD (≥4mm ) with CAL ( ≥1mm). All participants were instructed not to eat or drink (except water) at least 1 hour prior to collection of saliva. The subject should sit in a relaxed position. Samples were collected between 9-12 am. After the subject rinse his mouth several times by bottled water and then wait for 1-2 minutes for water clearance, 5ml of whole unstimulated mixed saliva was collected into polyethylene tubes. Saliva should not be spat into the tube and samples containing blood were discarded, also the patient shouldn't swallow during the. Saliva then centrifuged at 4000 round per minute (rpm) for 15 minutes; this was done within one hour after collection to eliminate debris and cellular matter, the clear supernatant was separated by micropipette and transferred to eppendorf to be stored at (-20 ºC) till being analyzed. Four ml of blood was collected from the ante- cubital fossa by venipuncture using 5 ml disposable syringes and immediately transferred to lab. Samples were collected between 9-12 am. Blood sample was allowed to clot at room temperature and after one hour, serum was extracted from blood by centrifuging at 3000 rpm for 5 min. The extracted serum was immediately transferred to eppendorf and stored at (-20 ºC) till being analyzed. The Demeditec leptin and resistin Enzyme- Linked Immuno Sorbent Assay (ELISA) kits were used for quantitative measurement of their serum and salivary levels. Oral examination was done using periodontal probe on all teeth except 3rd molar on four surfaces. The collected data include: plaque index system, Gingival index, Bleeding on probing, probing pocket depth and Clinical attachment level. RESULTS The standard deviation (SD), standard error (SE), minimal (Min.) and maximal (Max.) values were obtained for each group. ANOVA table test was performed for Analysis of variance. The study had revealed that there is a highly significant difference in serum leptin levels at P< 0.01 among the studied groups as shown in table (1) and with mean value of (5.61) in group I, (8.10) in group II and (9.81) in group III. Table (1): Serum Leptin Levels (ng/ml) among Three Studied Groups. Group1Group2Group3P-value Mean 5.61 8.10 9.81 0.000 ** S.D. 1.19 0.97 1.15 S.E. 0.32 0.26 0.31 Min. 4.07 6.54 8.34 Max. 7.71 9.81 11.64 ** Highly significant difference at P<0.01. Table (2) showed that the mean salivary leptin in group I had the largest value (0.29 ng/ml) followed by group II (0.21 ng/ml ) and the Group III had the smallest value (0.17 ng/ml) and also it revealed that there is highly significant difference between mean salivary levels at P< 0.01. Table (2): Salivary Leptin Levels (ng/ml) among Three Studied Groups. Group1Group2Group3P-value Mean 0.29 0.21 0.17 0.000 ** S.D. 0.04 0.04 0.04 S.E. 0.01 0.01 0.01 Min. 0.22 0.13 0.10 Max. 0.36 0.27 0.23 ** Highly significant difference at P<0.01. There is a significant difference in mean serum resistin levels at P<0.05 with highest mean value in chronic periodontitis patient (group III) (6.5 ng/ml) and lowest mean value in healthy control group (group I) (5.45ng/ml) that was seen in table (3). J Bagh College Dentistry Vol. 27(4), December 2015 Antibacterial effect Oral and Maxillofacial Surgery and Periodontics 121 Table (3): Serum Resistin Levels (ng/ml) among Three Studied Groups. Group1Group2Group3P-value Mean 5.45 5.85 6.55 0.032 * S.D. 0.60 0.97 1.45 S.E. 0.16 0.26 0.39 Min. 4.70 4.37 4.71 Max. 6.30 7.50 8.85 *Significant difference at P<0.05. Periodontitis individuals presented the lowest serum leptin levels than periodontitis patients and stating that periodontitis affected the circulating levels of leptin in favor of pro-inflammation (19). A recent study have stated that serum level of leptin was significantly higher in chronic periodontitis patients when compared to healthy controls suggesting that chronic periodontitis upregulated the circulating level of leptin in subjects with normal BMI (20). There was an association of periodontal conditions with serum leptin levels, since its levels was influenced by (21). Regarding salivary level of resistin the present study revealed that the level of salivary resistin in chronic periodontitis group (14.45) was significantly higher at P<0.01 than the other two groups with lowest level in healthy group (6.43), LPS stimulation in human. Controversy was also seen in regard to association between circulating leptin and periodontitis as the result of this was disagreed with Davies et al who stated that the level of serum leptin was not significantly different between the aggressive periodontitis patients (22). All that was shown in table (4). Healthy subjects A recent study has pointed out that serum levels of leptin and soluble leptin receptor do not vary between patients and with different periodontal conditions (23). The possible explanation for this is due to the fact that Porphyromonas gingivalis (P. gingivalis) which is a G -ve bacterium found in periodontal pockets of patients with periodontitis and strongly implicated in the pathogenesis of periodontal disease (24,25). Table (4): Salivary Resistin Levels (ng/ml) among Three Studied Groups. Group1Group2Group3P-value Mean 6.43 11.59 14.45 0.000 ** S.D. 0.81 1.60 1.88 S.E. 0.22 0.43 0.50 Min. 4.63 8.65 11.60 Max. 7.89 13.77 17.84 ** Highly significant difference at P<0.01. DISCUSSION Lipopolysaccharide (LPS) is virulent factor of the bacterium leading to the development of inflammatory responses that characterize periodontitis (26). Leptin Significantly enhanced P. gingivalis LPS induced IL-18 release suggesting a possible interaction between leptin and periodontal bacteria in modulating host (27). Interestingly, this study had showed that the immune responses. Leptin was shown to circulating level of leptin in serum was correlated positively with transition from periodontal health to disease. Many researchers have studied the relation of leptin to various forms of periodontal disease using different types of samples their results seemed to be in enhancing toll like receptor (TLR) expression and the secretion of cytokines in monocytes and may thereby potentiate immune responses to periodontal pathogens (28). There are significant differences between leptin action in the circulation and locally within (29) accordance to a certain degree with the result of the gastrointestinal lumen. Studies suggested the present study. This is in agreement with a study done by Gangadhar and his colleagues who declared that the serum leptin concentrations were found to increase as the gingival disease progressed (11). It also in agreement with Karthikeyan and Pradeep who suggest that greater the periodontal destruction, greater is the serum leptin concentration and the lowest serum leptin concentration was found in healthy individuals (10). A multifunctional role of leptin released locally within peripheral tissues and that secreted into saliva by the acinar cells of salivary glands, have brought to the forefront its importance in the processes of mucosal defense and repair along alimentary tract, including that of oral cavity and gingiva as salivary leptin potently stimulate the expression of two cytokines relevant to keratinocyte proliferation, salivary leptin increases proliferation of oral keratinocytes (30-32). The present study come in line with Shimada et, al., who found that there was a significant sublingual salivary gland acinar cells against (33) differences between healthy and chronic ethanol cytotoxicity, that exogenous leptin periodontitis patients in serum leptin levels (18). On other hand, Zimmermann et, al., showed that non-known to accelerate wound repair, it contributes to the inhibition of bacterial growth by mucins, since it prevents the reduction of salivary mucin synthesis evoked by oral bacterial LPS, that gingival leptin was known for its protective role in periodontal disease (34-39). J Bagh College Dentistry Vol. 27(4), December 2015 Antibacterial effect Oral and Maxillofacial Surgery and Periodontics 122 Moreover, the result of the present study showed that there is a highly significant difference in mean salivary leptin levels among the studied groups at P< 0.01, with group I had the highest value and the Group III had the lowest one. This in contrast to what we have found in relation to circulatin leptin level, but these finding be consistent with a study by Ducroc et, al., as they showed that there are significant differences between leptin action in the circulation and locally within the gastrointestinal lumen (29). Little information was known about the association between salivary leptin level and periodontal disease. Though a study showed that there were no differences in the distribution of leptin single nucleotide polymorphism (-2548G/A SNP) genotypes (leptin genetics) in saliva of 50 subjects between control and periodontitis subjects (40). In regards to circulating resistin the result of the present study illustrated that there was a significant difference in mean serum resistin levels with highest mean value in chronic periodontitis patient and the lowest mean value in healthy control. These consequences were in accordance with a Japanese study which declared that increased serum resistin levels were significantly associated with periodontal condition in elderly people (15). Also it matched with Zimmermann and colleagues who found that serum resistin level was higher in periodontitis than in non-periodontitis (19). Coming in line with another Japanese study which stated that having periodontitis was significantly associated with an increased level of serum resistin (16). Recently, Duarte et, al., have found that serum levels of resistin were significantly higher in chronic periodontitis subjects when compared to healthy controls. Suggesting that chronic periodontitis upregulated the circulating levels of resistin in subjects with normal BMI (20). Even though there were number of researchers have disagreed in part or as whole with our findings. There was not much difference in the serum resistin levels between the chronic periodontitis and the healthy controls. Also the decrease in the resistin levels following nonsurgical periodontal therapy did not show any statistical significance(41). Serum resistin levels have not presented any significant differences between the periodontally healthy and ligature induced periodontitis in rats(42). Resistin concentrations in serum was not associated with periodontitis (43). This rise in serum resistin in periodontal disease can be explained logically in the context of the following studies which showed that circulating resistin concentration was increased in response to LPS and/or leukotoxin that were produce by common peridontopathic bacteria; inflammatory cells such as monocytes and macrophages present in the periodontal tissue appear to be the major source of resistin (15). Resistin release from neutrophils was induced by both P. gingivalis and Escherichia coli (E. coli) LPS(44). Increased resistin in several inflammatory cells stimulated by periodontal pathogenic components such as LPS(45). There was an association of Periodontal conditions with serum resistin levels, since its levels was dramatically increased by LPS stimulation in humans (21,46-49). Furugen et al showed that A. a expressed leukotoxin that induces extracellular release of human neutrophil derived resistin and suggested that increased prevalence and levels of A. a in periodontal patients contribute to their higher circulating levels of resistin (50). Moreover, resistin was shown to mediate its proinflammatory effects via TLR-4 (51). The expression level of TLR-4 was higher in all periodontal patients than in healthy individuals(52). There was no data provided in the surveyed periodontal literature regarding local level of resistin in saliva of patients with periodontal disease. Even though, a number of studies have investigated the local resistin in GCF but not in the gingival tissue. The present study revealed that the level of salivary resistin in chronic periodontitis group was significantly higher than the other two groups with lowest level in healthy control group and that of gingivitis group was intermediate between them. The level of salivary resistin were upregulated locally in the salivary glands in case of inflammation in patient with primary Sjögren's syndrome; and the levels of resistin correspond to the intensity of lymphocytic inflammation (53). Based on this fact we may explain and illustrate that the salivary resistin were upregulated locally in the salivary glands in relation to inflammation caused be the inflammatory periodontal diseases. REFERENCES 1. Faizuddin M, Bharathi SH, Rohini NV. Estimation of interleukin-1beta levels in the gingival crevicular fluid in health and in inflammatory periodontal disease. J Periodontal Res 2003; 38(2): 111-4. 2. Lamster IB, Kaufman E, Grbic JT, et al. Beta- glucuronidase activity in saliva: relationship to clinical periodontal parameters. J Periodontol 2003; 74: 353-9. 3. Miller CS, King CP Jr, Langub MC, et al. Salivary biomarkers of existing periodontal disease: a cross- sectional study. J Am Dent Assoc 2006; 137(3):322-9. 4. Gonçalves Lda R, Soares MR, Nogueira FC, et al. Comparative proteomic analysis of whole saliva J Bagh College Dentistry Vol. 27(4), December 2015 Antibacterial effect Oral and Maxillofacial Surgery and Periodontics 123 from chronic periodontitis patients. J Proteomics 2010; 73(7): 1334-41. 5. Gemmell E, Seymour GJ. Immunoregulatory control of Th1/Th2 cytokine profiles in periodontal disease. Periodontol 2000 2004; 35: 21-41. 6. Garlet GP, Cardoso CR, Silva TA, et al. Cytokine pattern determines the progression of experimental periodontal disease induced by Actinobacillus actinomycetemcomitans through the modulation of MMPs RANKL, and their physiological inhibitors. Oral Microbiol Immunol 2006; 21:12-20. 7. Zhang, Y, Proenca R, Maffei M, et al. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-32. 8. Ahima RS, Flier JS. Leptin. Annual Review of Physiology 2000; 62: 413–37. 9. Sarraf P, Frederich RC, Turner EM, et al. Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia. J Exp Med 1997; 185: 171-5. 10. Karthikeyan BV, Pradeep AR. Gingival crevicular fluid and serum leptin: their relationship to periodontal health and disease. J Clin Periodontol 2007; 34(6): 467-72 (IVSL). 11. Gangadhar V, Ramesh A, Thomas B. Correlation between leptin and the health of the gingiva: A predictor of medical risk. Indian J Dent Res 2011; 22: 537-41. 12. Savage DB, Sewter CP, Klenk ES, et al. Resistin/fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans. Diabetes 2001; 50: 2199-202. 13. Silswal N, Singh AK, Aruna B, Mukhopadhyay et al. Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kB-dependent pathway. Biochem Biophys Res Commun 2005; 334: 1092- 101. 14. Lu SC, Shieh WY, Chen CY, et al. Lipopolysaccharide increases resistin gene expression in vivo and in vitro. FEBS Lett 2002; 530: 158-62. 15. Furugen R, Hayashida H, Yamaguchi N, et al. The relationship between periodontal condition and serum levels of resistin and adiponectin in elderly Japanese. J Periodontal Research. 2008; 43(5): 556-62 (IVSL). 16. Saito T, Yamaguchi N, Shimazaki Y, et al. Serum levels of resistin and adiponectin in women with periodontitis: the Hisayama study. J Dent Res 2008; 87: 319-22. 17. Thommesen L, Stunes AK, Monjo M, et al. Expression and regulation of resistin in osteoblasts and osteoclasts indicate a role in bone metabolism. J Cell Biochem 2006; 99: 824-34. 18. Shimada Y, Komatsu Y, Ikezawa-Suzuki I, et al. The effect of periodontal treatment on serum leptin, interleukin-6, and C-reactive protein. J Periodontol. 2010; 81(8): 1118-23. 19. Zimmermann GS, Bastos MF, Dias Gonçalves TE, et al. Local and circulating levels of adipocytokines in obese and normal weight individuals with chronic periodontitis. J Periodontol 2013; 84: 624-33. 20. Duarte PM, Goncalves TE, Bastos MF, et al. Circulating Levels of Adipocytokines in Non-Obese Subjects with Chronic Periodontitis. J Dent Res 2012; 91(Spec Iss A): 1508. 21. Anderson PD, Mehta NN, Wolfe ML, et al. Innate immunity modulates adipokines in humans. J Clin Endocrinol Metab 2007; 92: 2272–79. 22. Davies RC, Jaedicke KM, Barksby HE, et al. Do patients with aggressive periodontitis have evidence of diabetes? A pilot study. J Periodont Res 2011; 46: 663–2. 23. Ay ZY, Kırzıoğlu FY, Tonguç MO, et al. The gingiva contains leptin and leptin receptor in health and disease. Odontol 2012; 100(2): 222-31. (IVSL). 24. Fox CH. New considerations in the prevalence of periodontal disease. Curr Opin Dent 1992; 2: 5-11. 25. Ximenez-Fyvie LA, Haffajee AD and Socransky S. Microbial composition of supra- and subgingival plaque in subjects with adult periodontitis. J Clin Microbiol 2000; 27: 722 -32. 26. Wang PL, Ohura K. Porphyromonas gingivalis lipopolysaccharide signaling in gingival fibroblasts – CD14 and Toll-like receptors. Crit Rev Oral Biol Med 2002; 13:132-42. 27. Jitprasertwong P, Jaedicke KM, Preshaw PM et al. Leptin regulates IL-18 processing and release in human monocytes. J Dent Res 2010; 89(Spec Iss B): 2020. 28. Taylor JJ, Jaedicke K, Jitpraserwong P,et al. Monocyte Responses to Bacterial LPS are Enhanced by Leptin . J Dent Res 2009; 88(Spec Iss A): 1367. 29. Ducroc R, Guilmeau S, Akasbi K, et al. Luminal leptin induces inhibition of active intestinal absorption of glucose mediated by sodium-glucose co-transporter, SGLT-1. Diabetes 2005; 54; 348–54. 30. Alison MR, Sarraf CE . The role of growth factors in gastrointestinal cell proliferation. Cell Biology International 1994; 18: 1–10. 31. Slonina D, Hoinkis C & Dörr W. Effect of keratinocyte growth factor on radiation survival and colony size of human epidermal keratinocytes in vitro. Radiation Res 2001; 156: 761-6. 32. Gröschl M, Topf HG, Kratzsch J, et al. Salivary leptin induces increased expression of growth factors in oral keratinocytes. J Mol Endocrinol 2005; 34(2): 353-66. 33. Slomiany BL & Slomiany A. Leptin protection of salivary gland acinar cells against ethanol cytotoxicity involves Src kinase-mediated parallel activation of prostaglandin and constitutive nitric oxide synthase pathways. Inflammo Pharmacol 2008; 16: 76-82. 34. Bado A, Levasseur S, Attoub S, et al. The stomach is a source of leptin. Nature 1998; 394(6695):790-3. 35. Frank S, Stallmeyer B, Kampher H et al. Leptin enhances wound re-epithelization and constitutes a direct function of leptin in skin repair. J Clin Invest 2000; 106: 501-9. 36. Gröschl M, Rauh M, Wagner R, et al. Identification of leptin in human saliva. J Clin Endocrinol Metab 2001; 86: 5234-9. 37. Johnson RB, Serio FG. Leptin within healthy and diseased human gingiva. J Periodontol 2001; 72; 1254-7. 38. Slomiany B, Slomiany A. Leptin suppresses Porphyromonas gingivalis lipopolysaccharide interference with salivary mucin synthesis. Biochemical and Biophysical Research Communications 2003; 312: 1099–103. 39. Slomiany BL, Slomiany A. Role of endothelin-1- dependent up-regulation of leptin in oral mucosal repair. J Physiol Pharmacol 2005; 56: 531-41. 40. Morillo JM, Cordero MD, Battino M, et al. Lack of association between leptin-2548G/A polymorphism and periodontitis. J Dent Res 2010; 89(Spec Iss B): 3409. J Bagh College Dentistry Vol. 27(4), December 2015 Antibacterial effect Oral and Maxillofacial Surgery and Periodontics 124 41. Devanoorkar A, Dwarakanath CD, Gundanavar G, et al. Evaluation of serum resistin levels in periodontal health and disease and effects of non surgical periodontal therapy on its levels. Dis Markers 2012; 32(5): 289-94. 42. Çağlar F, Yetkin Ay Z, D Kumbul Doğuc D, et al. The Serum Levels of Cytokines and Adipokines in Obese Rats With Periodontitis. European Federation of Periodontol 2012; P0055 (Poster Abstracts). 43. Al-shahwani RM, Wassall RR, Jaedicke KM, et al. Analysis of resistin in patients with periodontal disease and diabetes. J Dent Res 2011; 90(Spec Iss A): 2818. 44. Furugen R, Hayashida H, Saito T. Porphyromonas gingivalis and Escherichia coli lipopolysaccharide causes resistin release from neutrophils. Oral Dis 2012; 45. Furugen R , Hayashida H, and Saito T. Resistin expression by lipopolysaccharide of Porphyromonas gingivalis in monocytic/macrophage-like cells. J Dent Res 2010; 89 (Spec Iss B): 2641. 46. Lehrke M, Reilly MP, Millington SC, et al. An inflammatory cascade leading to hyperresistinemia in humans. PLoS Med 2004; 1: e45. 47. Johansson L, Linner A, Sunde´n-Cullberg J, et al. Neutrophil-derived hyperresistinemia in severe acute Streptococcal infections. J Immunol 2009; 183: 4047-54. 48. Kopp A, Buechler C, Neumeier M et al. Innate immunity and adipocyte function: ligand-specific activation of multiple Toll-like receptors modulates cytokine, adipokine, and chemokine secretion in adipocytes. Obesity 2009; 17: 648-56. 49. Hiroshima Y, Bando M, Inagaki Y et al. Resistin in gingival crevicular fluid and induction of resistin release by Porphyromonas gingivalis lipopolysaccharide in human neutrophils. J Periodont Res 2012. 50. Furugen R, Hayashida H, Yoshii Y, et al. Neutrophil- derived resistin release induced by Aggregatibacter actinomycetemcomitans. FEMS Microbiology Letters 2011; 321:175-82. 51. Tarkowski A, Bjersing J, Shestakov A, et al. Resistin competes with lipopolysaccharide for binding to Toll- like receptor 4. J Cell Mol Med 2010; 14(6B):1419- 31. 52. Rojo-Botello NR, García-Hernández AL, Moreno- Fierros L. Expression of toll-like receptors 2, 4 and 9 is increased in gingival tissue from patients with type 2 diabetes and chronic periodontitis. J Periodontal Res 2012; 47(1): 62-73. 53. Boström EA, d'Elia HF, Dahlgren U, et al. Salivary resistin reflects local inflammation in Sjögren's syndrome. J Rheumatol 2008; 35(10): 2005-11.